Kassberg Thomas Richard - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 11, 2024, Kassberg Thomas Richard's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Officer (CBO & EVP), and currently has 252,823 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RARE insiders.
Data Source: SEC.
Kassberg Thomas Richard - Insider Non-Derivative Transactions of RARE Common Stock
Kassberg Thomas Richard - Insider Non-Derivative Transactions at RARE
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Mar 12, 2024 | Sell -- (Common Stock) | 11509 | 49.93 | 252823 |
Mar 2, 2024 | Sell -- (Common Stock) | 1011 | 53.76 | 264332 |
Mar 2, 2024 | Acquisition -- (Common Stock) | 17800 | 0 | 264660 |
Mar 2, 2024 | F -- (Common Stock) | 274 | 53.69 | 265343 |
Mar 2, 2024 | Acquisition -- (Common Stock) | 957 | 0 | 265617 |
Oct 24, 2023 | Sell -- (Common Stock) | 39878 | 32.78 | 246860 |
Oct 24, 2023 | M -- (Common Stock) | 39878 | 6.86 | 286738 |
Mar 2, 2023 | Acquisition -- (Common Stock) | 2663 | 0 | 230222 |
Mar 2, 2023 | Disposition -- (Common Stock) | 3394 | 45.65 | 246860 |
Mar 2, 2023 | Sell -- (Common Stock) | 1968 | 45.27 | 250254 |
Mar 2, 2023 | Acquisition -- (Common Stock) | 22000 | 0 | 252222 |